ArticleBritish journal of haematology2026

Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapies.

Miles Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.